The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Characterization of tumor necrosis factor-deficient mice
Abstract
Although tumor necrosis factor (TNF) initially came to prominence because of its anti-tumor activity, most attention is now focused on its proinflammatory actions. TNF appears to play a critical role in both early and late events involved in inflammation, from localizing the noxious agent and amplifying the cellular and mediator responses at the local site and systemically, to editing (e.g., apoptosis) injured cells or effete immune cells and repairing inflammatory damage. We have generated mice deficient in TNF (TNF −/− mice) and have begun to examine the multiple functions attributed to TNF. TNF −/− mice develop normally and have no gross structural or morphological abnormalities. As predicted, they are highly susceptible to challenge with an infectious agent ( Candida albicans ), are resistant to the lethality of minute doses of lipopolysaccharide (LPS) following D-galactosamine treatment, have a deficiency in granuloma development, and do not form germinal centers after immunization. Phagocytic activity of macrophages appears relatively normal, as do T cell functions, as measured by proliferation, cytokine release, and cytotoxicity. B cell response to thymus-independent antigens is normal, but the Ig response to thymus-dependent antigen is reduced. Surprisingly, cytokine production induced by LPS appears essentially intact, with the exception of reduced colony-stimulating factor activity. Other unexpected findings coming from our initial analysis are as follows. ( i ) TNF has low toxicity in TNF −/− mice. ( ii ) TNF −/− mice show an anomalous late response to heat-killed Corynebacterium parvum . In contrast to the prompt response (granuloma formation, hepatosplenomegaly) and subsequent resolution phase in C. parvum -injected TNF +/+ mice, similarly treated TNF −/− mice show little or no initial response, but then develop a vigorous, disorganized inflammatory response leading to death. These results suggest that TNF has an essential homeostatic role in limiting the extent and duration of an inflammatory process—i.e., an anti-inflammatory function. ( iii ) In contrast to the expectation that TNF +/+ mice and TNF +/− mice would have identical phenotypes, TNF +/− mice showed increased susceptibility to high-dose LPS lethality, increased susceptibility to Candida challenge, and delayed resolution of the C. parvum -induced inflammatory process, indicating a strong gene dose requirement for different actions of TNF.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TNF, PGE2, and TLR activation have been linked to chronic granulomatous inflammation such as in tuberculosis or granulomatous listeriosis”
From Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation (2014) · cites this paper as Marino et al., 1997
In the citing paper
“Further characterization of individual programs identified transcription factors associated with particular phenotypes, such as STAT4, which was associated with stimuli linked to chronic inflammation (TNF, prostaglandin E2, TLR2-ligand, ''TPP'') as seen in granulomatous diseases”
From Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation (2014) · cites this paper as Marino et al., 1997
Citations
Cites
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Self-citationQian, Q., Jutila, M. A., Van Rooijen, N., & Cutler, J. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5000 · Cited by 246
Research works printed but not linked: 38
- , ed B Beutler (Raven, New York Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine, 1992).
- , eds B B Aggarwal, J Vilček (Dekker, New York Tumor Necrosis Factors: Structure, Function, and Mechanism of Action, 1992).
- 10.1126/science.8171316 · DOI
- 10.1126/science.8171323 · DOI
- 10.1016/0092-8674(93)90134-C · DOI · Paper page
- 10.1038/364798a0 · DOI
- 10.1038/372560a0 · DOI
- 10.1126/science.8171322 · DOI
- T A Banks, B T Rouse, M K Kerley, P J Blair, V L Godfrey, N A Kuklin, D M Bouley, J Thomas, S Kanangat, M L Mucenski J Immunol 155, 1685–1693 (1995). · DOI
- 10.1084/jem.183.5.2367 · DOI
- 10.1084/jem.184.4.1397 · DOI
- F Amiot, Y Bellkaid, M Lebastard, P Ave, F Dautry, G Milon Eur Cytokine Network 7, 733–739 (1996).
- 10.1084/jem.184.1.259 · DOI
- 10.1126/science.271.5253.1289 · DOI
- B Ryffel, F Di Padova, M H Schreier, M Le Hir, H P Eugster, V F Quesniaux J Immunol 158, 2126–2133 (1997). · DOI
- 10.1016/0092-8674(91)90011-M · DOI
- 10.1242/dev.113.4.1325 · DOI
- A Bradley Teratocarcinomas and Embryonic Stem Cells: A Practical Approach, ed E J Robertson (IRL, Oxford), pp. 152–178 (1987).
- 10.1016/0022-1759(86)90322-4 · DOI
- 10.1016/S0076-6879(85)16044-1 · DOI
- 10.3109/08977199409001056 · DOI
- 10.1016/0022-1759(94)00247-T · DOI
- E J Coligan, A M Kruisbeek, D H Margulies, E M Schevach, W Strober Current Protocols in Immunology (Wiley, New York) 3, 14.0.3–14.9.3 (1994).
- H P Redmond, J Shou, H J Gallagher, C J Kelly, J M Daly J Immunol 150, 3427–3433 (1993). · DOI
- G Biozzi, B Benacerraf, B N Halpern Br J Pathol 34, 441–457 (1953).
- B S Kelly, J G Levy, L Sikora Immunology 37, 45–52 (1979).
- 10.1002/eji.1830220412 · DOI
- 10.1016/S0021-9258(18)71615-3 · DOI
- S Steinshamn, M H Bemelmans, L J van Tits, K Bergh, W A Buurman, A Waage J Immunol 157, 2155–2159 (1996). · DOI
- 10.1016/1074-7613(95)90001-2 · DOI
- 10.1056/NEJM199606273342603 · DOI
- 10.1084/jem.175.6.1759 · DOI
- 10.1016/0092-8674(89)90676-4 · DOI
- 10.1038/356604a0 · DOI
- 10.1038/nm0796-788 · DOI
- L Q Vieira, M Goldschmidt, M Nashleanas, K Pfeffer, T Mak, P Scott J Immunol 157, 827–835 (1996). · DOI
- S Kondo, B Wang, H Fujisawa, G M Shivji, B Echtenacher, T W Mak, D N Sauder J Immunol 155, 3801–3805 (1995). · DOI
- T Zhou, C K Edwards, P Yang, Z Wang, H Bluethmann, J D Mountz J Immunol 156, 2661–2265 (1996). · DOI
Cited by
Sorted by citations
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Self-citationTranscriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Vogl, T., Tenbrock, K., Ludwig, S., Leukert, N., Ehrhardt, C., van Zoelen, M. A. D., Nacken, W., Foell, D., van der Poll, T., Sorg, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1638 · Cited by 1,418
Metadata
- Authors
- Marino, M. W., Dunn, A., Grail, D., Inglese, M., Noguchi, Y., Richards, E., Jungbluth, A., Wada, H., Moore, M., Williamson, B., Basu, S., & Old, L. J.
- Affiliations
- Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan–Kettering Cancer Center, 1275 York Avenue, New York, NY 10021; Ludwig Institute for Cancer Research, Melbourne Branch, P.O. Box Royal Melbourne Hospital, Melbourne, Australia, 3050; and Department of Experimental Hematology, Memorial Sloan–Kettering Cancer Center, 1275 York Avenue, New York, NY 10021
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1997-07-22
- Volume
- 94
- Issue
- 15
- Pages
- 8093-8098
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 622
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review